BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chaudhuri KR, Rukavina K, McConvey V, Antonini A, Lorenzl S, Bhidayasiri R, Piemonte MEP, Lim SY, Richfield E, Walker R, Bouca-Machado R, Bajwah S, Gao W, Trivedi D, Miyasaki J. The impact of COVID-19 on palliative care for people with Parkinson's and response to future pandemics. Expert Rev Neurother 2021;21:615-23. [PMID: 33905283 DOI: 10.1080/14737175.2021.1923480] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Hou L, Li W, Wang Q, Zhou W, Yang H. Referral criteria to palliative care for patients with Parkinson's disease: a systematic review. Curr Med Res Opin 2023;39:267-79. [PMID: 36369847 DOI: 10.1080/03007995.2022.2146405] [Reference Citation Analysis]
2 Rogers A, Richfield EW, Thomas S, Wee B, Trotter SA. Parkinson’s disease and palliative care: a quality of care Delphi study. BMJ Support Palliat Care 2022. [DOI: 10.1136/spcare-2022-003904] [Reference Citation Analysis]
3 Poonja S, Chaudhuri KR, Miyasaki JM. Movement disorders in coronavirus disease 2019 times: impact on care in movement disorders and Parkinson disease. Curr Opin Neurol 2022. [PMID: 35787539 DOI: 10.1097/WCO.0000000000001075] [Reference Citation Analysis]
4 Valdovinos BY, Modica JS, Schneider RB. Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research. Curr Neurol Neurosci Rep 2022. [PMID: 35107786 DOI: 10.1007/s11910-022-01178-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chandra A, Johri A. A Peek into Pandora’s Box: COVID-19 and Neurodegeneration. Brain Sciences 2022;12:190. [DOI: 10.3390/brainsci12020190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Varrassi G, Rekatsina M. Updates on Palliative Medicine in the COVID-19 Era. J Clin Med 2022;11:315. [PMID: 35054011 DOI: 10.3390/jcm11020315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Podlewska AM, van Wamelen DJ. Parkinson's disease and Covid-19: The effect and use of telemedicine. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.04.002] [Reference Citation Analysis]
8 Rukavina K, Mcconvey V, Ray Chaudhuri K, Miyasaki J. Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.03.004] [Reference Citation Analysis]
9 Behl T, Kumar S, Sehgal A, Singh S, Sharma N, Chirgurupati S, Aldubayan M, Alhowail A, Bhatia S, Bungau S. Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D. Biochem Biophys Res Commun 2021;583:14-21. [PMID: 34715496 DOI: 10.1016/j.bbrc.2021.10.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Luis-Martínez R, Di Marco R, Weis L, Cianci V, Pistonesi F, Baba A, Carecchio M, Biundo R, Tedesco C, Masiero S, Antonini A. Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown. BMC Neurol 2021;21:332. [PMID: 34461838 DOI: 10.1186/s12883-021-02364-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]